Northwire Canada EditionFriday, October 16, 2026
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
M&A / Property

Tilray Medical, CC Pharma, and 14U Pharma Announce Strategic Alliance with "gesund leben" Cooperation and Alliance Healthcare Deutschland to Accelerate Market Expansion and Strengthen Pharmacy Access Across Germany

TLRY · Price

Executive Summary

  • Tilray Pharma (Tilray Brands’ pharmaceutical division) announced a strategic partnership with Tilray Medical, CC Pharma, 14U Pharma and the “gesund leben” cooperation operated by Alliance Healthcare Deutschland.
  • Effective April 1 2026 the partners will combine distribution networks to supply ~3,600 German pharmacies with prescription medicines, parallel‑import discounted drugs and Tilray’s medical cannabis portfolio.
  • The alliance gives CC Pharma preferred access to >20% of German pharmacies and expands its reach to over 16,000 pharmacies nationwide, strengthening Tilrow’s market presence in Germany.

Key Details

  • Partnership Scope: Collaboration among Tilray Medical, CC Pharma, 14U Pharma and Alliance Healthcare Deutschland’s “gesund leben” network.
  • Effective Date: April 1 2026.
  • Network Reach: “gesund leben” cooperation includes approximately 3,600 member pharmacies; Alliance Healthcare operates 27 logistics centres serving >10,000 pharmacies daily.
  • Product Offering: Prescription medications (Rx), discounted parallel‑import medicines, and Tilray Medical’s medical cannabis portfolio.
  • Benefits to Pharmacies: Competitive purchasing terms, digital/priority access, expanded product availability, operational efficiency services, marketing support, and customized assistance.
  • CC Pharma Access: Preferred access to >20% of German pharmacies; currently supports >16,000 pharmacies across Germany.
  • Strategic Rationale (CEO Quote): “Germany remains one of the most important and dynamic healthcare markets in Europe… scaling our German operations, expanding pharmacy access, and creating an even more powerful platform for long‑term growth.” – Rajnish Ohri, President, International, Tilray Brands.
  • CC Pharma Comment (MD Quote): Emphasized new level of partnership to set “new standards in access, service, and innovation for pharmacies and patients across Germany.” – Mathias Bossen, Managing Director, CC Pharma.

Notable Quotes

“Germany remains one of the most important and dynamic healthcare markets in Europe… we are stronger together — scaling our German operations, expanding pharmacy access, and creating an even more powerful platform for long‑term growth.” – Rajnish Ohri, President, International, Tilray Brands

“Our long‑standing partnership with Alliance Healthcare Deutschland is being taken to a new level through this strategic cooperation… setting new standards in access, service, and innovation for pharmacies and patients across Germany.” – Mathias Bossen, Managing Director, CC Pharma

Read the original news release →

More from TILRAY BRANDS, INC. J